C12N 2795/14144
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2795/14144 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 5
- Assignees
- 3
- Inventors
- 8
- Latest grant
- 17 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 2 | 2 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Cancer Treatment28 Mar 2024US 2024/0101628 A1Imperial College Innovations Limited
- Treatment delivery system and method14 Sep 2023US 2023/0285508 A1SynPhaGen LLC
- Phagemid Vector24 Aug 2023US 2023/0265452 A1Imperial College Innovations Limited
- Cancer Treatment30 Jul 2020US 2020/0239535 A1Imperial Innovations Limited
- Phagemid Vector8 Nov 2018US 2018/0320200 A1Imperial Innovations Limited
Most cited
By later US patents